Skip to main content
. 2017 Jan 27;8(10):16488–16497. doi: 10.18632/oncotarget.14870

Table 1. VEGFA genotype and allele frequencies of the cases and controls and their association with risk of HCC.

Polymorphism Genotype/allele HCC (n = 476) controls (n = 526) Crude OR 95% CI Pa value Adjusted ORb 95% CI Pc value
VEGF CC 359 (75.4)d 370 (70.3) 1.00 1.00
936 C/T CT 112 (23.5) 140 (26.6) 0.83 [0.62,1.10] 0.188 0.84 [0.60,1.19] 0.325
TT 5 (1.1) 16 (3.1) 0.32 [0.12,0.89] 0.021 0.54 [0.17,1.70] 0.295
Genotypes CT and TT 117 (24.6) 156 (29.7) 0.77 [0.58,1.02] 0.071 0.81 [0.58,1.13] 0.221
Alleles T 0.128 0.163
VEGF GG 162 (34.0) 200 (38.0) 1.00 1.00
634G/C GC 232 (48.8) 248 (47.2) 1.16 [0.88,1.52] 0.302 1.10 [0.79,1.53] 0.583
CC 82 (17.2) 78 (14.8) 1.30 [0.89,1.88] 0.170 1.13 [0.73,1.75] 0.590
Genotypes GC and CC 314 (66.0) 326 (62.0) 1.19 [0.92,1.54] 0.189 1.11 [0.81,1.51] 0.516
Alleles C 0.416 0.384
VEGF GG 254 (53.4) 296 (56.3) 1.00 1.00
1612G/A GA 188 (39.5) 198 (37.6) 1.11 [0.85,1.44] 0.447 1.22 [0.90,1.67] 0.203
AA 34 (7.1) 32 (6.1) 1.24 [0.74,2.06] 0.412 1.16 [0.64,2.11] 0.628
Genotypes GA and AA 222 (46.6) 230 (43.7) 1.13 [0.88,1.44] 0.355 1.21 [0.90,1.63] 0.209
Alleles A 0.269 0.249
VEGF CC 301 (63.2) 290 (55.1) 1.00 1.00
2578C/A CA 157 (33.0) 202 (38.4) 0.75 [0.58,0.98] 0.031 0.72 [0.53,0.98] 0.041
AA 18 (3.8) 34 (6.5) 0.51 [0.28,0.92] 0.024 0.48 [0.24,0.96] 0.038
Genotypes CA and AA 175 (36.8) 236 (44.9) 0.71 [0.55,0.92] 0.009 0.69 [0.51,0.93] 0.014
Alleles A 0.203 0.257
a

P value for crude odds ratio (OR) and 95% confidence interval (CI).

b

Adjusted for age, gender, HBV carrier state, family history of cancer, smoking, and drinking status.

c

P value for adjusted odds ratio (OR) and 95% confidence interval (CI).

d

Values in parentheses indicate percentages.